# Trimi Health reviews (2026): GLP-1 telehealth sellers | This GLP

Both monthly figures here are an annual plan divided by twelve, charged in a single payment at the start.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/trimi-health
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Annual plan, billed up front

# Trimi Health review

Both monthly figures here are an annual plan divided by twelve, charged in a single payment at the start.

## The verdict

Trimi Health advertises $99 a month for compounded semaglutide and $125 for compounded tirzepatide. Both are annual plans billed at once, at $1,188 and $1,500, or split through a buy-now-pay-later provider.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

Dose pricing

Flat across doses

States

50

Prescription

Required

Compounded

Yes — not FDA-approved

Trimi Health sells compounded semaglutide and compounded tirzepatide by injection, shipping to all fifty states. The figures on its page are the advertised headline rates, and both describe a twelve-month plan. Semaglutide is billed as $1,188 for the year and tirzepatide as $1,500. Affirm, Klarna and Afterpay are offered as ways to spread that charge.

1.  ## Who writes the prescription, and what do they see?
    
    Care is arranged remotely and a prescription is required before the first vial ships. The page prices a twelve-month plan rather than a course of clinician contact. How often a patient is seen across that year, and by whom, is not published. The annual charge is described as the cost of the plan, not as a fee for a visit.
    
    Care is arranged remotely and the plan runs for a year from the first payment. The rate is stated as flat across doses, so a titration does not move the figure. That matters most between month one and month four, when the dose usually rises. Whether a plan can be ended early, and on what terms, is not published.
    
2.  ## What happens when the dose goes up?
    
    The rate is stated as flat across doses, so an escalation leaves the figure alone. That claim is worth more here than at a month-to-month seller, because the whole year is already paid for. A reader who reaches a maintenance dose in month four is still on the rate agreed in month one. What happens if a clinician moves a patient to the other molecule mid-plan is not stated.
    
3.  ## What the price includes
    
    The monthly framing and the billing are different things here, and the second one is what a card is charged. $99 a month reads like a month-to-month rate and is an annual commitment of $1,188. The tirzepatide plan is $1,500, which works out at $125 across twelve months. A buy-now-pay-later arrangement spreads the payment without shortening the term.
    
4.  ## What it claims, and what it cites
    
    Both products are compounded, which means a pharmacy prepares them rather than a manufacturer. A compounded preparation is not FDA-approved and is not reviewed before it is dispensed. The published trial evidence for these molecules used the approved products at the doses on their labels. Whether a compounded vial matches those products in content or purity is not measured.
    

## Where it holds up, and where it does not

-   Strength: Rate stated as flat across doses
-   Strength: Annual cost published as a total
-   Strength: Ships to all fifty states
-   Limitation: Monthly figure is an annual plan
-   Limitation: Full year is charged at the start
-   Limitation: Financing spreads payment, not the term

## What the evidence says about this kind of treatment

The assessment above is about Trimi Health. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader who can pay a year at once, or finance it, and wants the monthly figure to stop moving as the dose rises.

Wrong for

A reader who wants to stop after a month or two, because the plan behind both figures is a twelve-month one charged up front.

## The evidence behind what Trimi Health prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Trimi Health compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Lean Meds | Readers willing to clarify the prescription and renewal details |  |
| Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. |  |
| Alloy | A reader comparing three molecules at one seller, where the same fixed fee sits on top of each of them. |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Harbor](https://thisglp.com/reviews/harbor) [Harmony Wellness Clinic](https://thisglp.com/reviews/harmony-wellness-clinic) [Harper Meds](https://thisglp.com/reviews/harper-meds) [He & She MD](https://thisglp.com/reviews/he-and-she-md) [Heally](https://thisglp.com/reviews/heally) [HealthHub](https://thisglp.com/reviews/healthhub)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Is $99 a month what the card is charged?

No. The plan is annual and the charge is $1,188 at the start, which is $99 across twelve months. Affirm, Klarna and Afterpay are offered to spread that payment.

Does the tirzepatide plan work the same way?

It does. The advertised $125 a month is a $1,500 annual plan billed on the same terms as the semaglutide one.

Will the price change as the dose goes up?

Trimi Health states a flat rate across doses. The figure therefore holds through the escalation, which is where many sellers in this category reprice.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
